30 minutes
With investor confidence in the biopharma industry at an all-time high (and driving record-breaking investment), emerging companies have more pathways to scale than ever before. Our panelists will discuss the current state of biopharma investment, including the SPAC boom of 2020, innovative partnerships, and projections for 2021 and beyond.


Chris Ehrlich - Chief Executive Officer, Locust Walk
Kristin Pothier - Global and National Healthcare and Life Sciences Strategy Leader, KPMG
Steve Gullans, PhD - Principal at Gullans Advisory, LLC
Vikas Goyal - Co-Founder & Managing Partner, Trekk Venture Partners